Amendment #297 to H5150

MelroseWakefield Healthcare, Inc

Representatives Lipper-Garabedian of Melrose, Donato of Medford, Ultrino of Malden and Wong of Saugus move to amend the bill in section 2, in line item 5095-0015, by adding the following: “; provided that not less than $300,000 shall be expended to MelroseWakefield Healthcare, Inc., for direct costs associate with COVID-19 treatment”; and in said item by striking out the figures “$229,635,223” and inserting in place thereof the figures “$229,935,223.”

Additional co-sponsor(s) added to Amendment #297 to H5150

MelroseWakefield Healthcare, Inc